The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease and the Heart
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both manifestations of end-organ damage of the metabolic syndrome. Through multiple pathophysiological mechanisms, CVD and NAFLD are associated with each other. Systemic inflammation, endothelial dysfunction, hepatic insulin resistance, oxidative stress, and altered lipid metabolism are some of the mechanisms by which NAFLD increases the risk of CVD. Patients with NAFLD develop increased atherosclerosis, cardiomyopathy, and arrhythmia, which clinically result in cardiovascular morbidity and mortality. Defining the mechanisms linking these 2 diseases offers the opportunity to further develop targeted therapies. The aim of this comprehensive review is to examine the association between CVD and NAFLD and discuss the overlapping management approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C., & Cao, C. Y. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00571.x · Cited by 93
RetractedYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 1×
“Liraglutide has been shown to improve glycemic control; reduce total cholesterol, LDL, and TG; reduce systolic blood pressure; and decrease the incidence of nonfatal myocardial infarction, nonfatal stroke, heart failure admissions, and death due to any cardiovascular cause (152,153).”
BackgroundChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Self-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Self-citationArmstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,101
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024 · cited 1×
“In patients with NASH and impaired glucose tolerance or type 2 DM, pioglitazone has been shown to decrease hepatic fat content; increase hepatic insulin sensitivity; decrease serum ALT levels; and improve fibrosis, steatosis, inflammation, and ballooning necrosis (145,146).”
BackgroundTargher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Sesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
Cusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Lazo, M., Hernaez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I., Guallar, E., Koteish, A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 797
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Birkenfeld, A. L., & Shulman, G. I. (2014) · Hepatology · doi:10.1002/hep.26672 · Cited by 738
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Athyros, V. G., Tziomalos, K., Gossios, T. D., Griva, T., Anagnostis, P., Kargiotis, K., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., & Mikhailidis, D. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61272-x · Cited by 685
Friedman, S. L., Ratziu, V., Harrison, S. A., Abdelmalek, M. F., Aithal, G. P., Caballeria, J., Francque, S., Farrell, G., Kowdley, K. V., Craxi, A., et al. (2018) · Hepatology · doi:10.1002/hep.29477 · Cited by 671 · cited 1×
“A randomized, double-blind, phase IIb study found that this medication resulted in a significant improvement in fibrosis without worsening NASH after the first year (167) and second year (168) of treatment.”
BackgroundCurrent and future pharmacological therapies for NAFLD/NASH
Sumida, Y., & Yoneda, M. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1415-1 · Cited by 667
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Mantovani, A., Byrne, C. D., Bonora, E., & Targher, G. (2018) · Diabetes Care · doi:10.2337/dc17-1902 · Cited by 624
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Francque, S. M., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 556
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., Motta, B. M., Kaminska, D., Rametta, R., Grimaudo, S., et al. (2015) · Hepatology · doi:10.1002/hep.27490 · Cited by 533 · cited 1×
“NAFLD due to increased retention of TG and lipids in the liver but may experience some degree of cardioprotection with subsequently reduced levels of serum TG, LDL cholesterol, and total cholesterol (57).”
BackgroundVascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
The role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9607 · Cited by 449
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.015 · Cited by 441
Self-citationThe Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Leamy, A. K., Egnatchik, R. A., & Young, J. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.004 · Cited by 412
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., & Lawlor, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-1870 · Cited by 385
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · cited 1×
“PNPLA3 modulates the morphology and physiology of lipid droplets and appears to be related to TG metabolism (52).”
BackgroundErdmann, E., Dormandy, J. A., Charbonnel, B., Massi-Benedetti, M., Moules, I. K., & Skene, A. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.048 · Cited by 378
Allen, A. M., Therneau, T. M., Larson, J. J., Coward, A., Somers, V. K., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.29546 · Cited by 370
Bariatric surgery and cardiovascular outcomes: a systematic review
Vest, A. R., Heneghan, H. M., Agarwal, S., Schauer, P. R., & Young, J. B. (2012) · Heart · doi:10.1136/heartjnl-2012-301778 · Cited by 336
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Björnsson, E., Jacobsen, E. I., & Kalaitzakis, E. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.023 · Cited by 321
Wu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep33386 · Cited by 318
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Anstee, Q. M., Mantovani, A., Tilg, H., & Targher, G. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0010-0 · Cited by 310
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310
VanWagner, L. B., Wilcox, J. E., Colangelo, L. A., Lloyd‐Jones, D. M., Carr, J. J., Lima, J. A., Lewis, C. E., Rinella, M. E., & Shah, S. J. (2015) · Hepatology · doi:10.1002/hep.27869 · Cited by 305
The CardioMetabolic Health Alliance
Sperling, L. S., Mechanick, J. I., Neeland, I. J., Herrick, C. J., Després, J.-P., Ndumele, C. E., Vijayaraghavan, K., Handelsman, Y., Puckrein, G. A., Araneta, M. R. G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1328 · Cited by 294
Self-citationAlcohol Consumption and Mortality in Patients With Cardiovascular Disease
Costanzo, S., Di Castelnuovo, A., Donati, M. B., Iacoviello, L., & de Gaetano, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.006 · Cited by 291
Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173499 · Cited by 287
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
Masuoka, H. C., & Chalasani, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12016 · Cited by 283
Self-citationFraser, A., Harris, R., Sattar, N., Ebrahim, S., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 277
An Assessment of Statin Safety by Hepatologists
Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 269
Self-citationStatins and hepatotoxicity: Focus on patients with fatty liver†
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 265
Self-citationBower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 256
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Non-alcoholic fatty liver disease and risk of cardiovascular disease
Lonardo, A., Sookoian, S., Pirola, C. J., & Targher, G. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236
Bi-directional analysis between fatty liver and cardiovascular disease risk factors
Ma, J., Hwang, S.-J., Pedley, A., Massaro, J. M., Hoffmann, U., Chung, R. T., Benjamin, E. J., Levy, D., Fox, C. S., & Long, M. T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.022 · Cited by 234
Siddiqui, M. S., Fuchs, M., Idowu, M. O., Luketic, V. A., Boyett, S., Sargeant, C., Stravitz, R. T., Puri, P., Matherly, S., Sterling, R. K., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.008 · Cited by 231
Dormandy, J., Bhattacharya, M., & van Troostenburg de Bruyn, A.-R. (2009) · Drug Safety · doi:10.2165/00002018-200932030-00002 · Cited by 227
Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
DeFilippis, A. P., Blaha, M. J., Martin, S. S., Reed, R. M., Jones, S. R., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.022 · Cited by 217
Lauridsen, B. K., Stender, S., Kristensen, T. S., Kofoed, K. F., Køber, L., Nordestgaard, B. G., & Tybjærg-Hansen, A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx662 · Cited by 213
Liao, H.-W., Saver, J. L., Wu, Y.-L., Chen, T.-H., Lee, M., & Ovbiagele, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013927 · Cited by 198
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., & Byrne, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057183 · Cited by 197
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
Tripodi, A., Fracanzani, A. L., Primignani, M., Chantarangkul, V., Clerici, M., Mannucci, P. M., Peyvandi, F., Bertelli, C., Valenti, L., & Fargion, S. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.013 · Cited by 192
An assessment by the Statin Liver Safety Task Force: 2014 update
Bays, H., Cohen, D. E., Chalasani, N., & Harrison, S. A. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.011 · Cited by 187
Self-citationMahfood Haddad, T., Hamdeh, S., Kanmanthareddy, A., & Alla, V. M. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.033 · Cited by 182
Georgescu, E. F., Ionescu, R., Niculescu, M., Mogoanta, L., & Vancica, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.942 · Cited by 177
Pareek, M., Schauer, P. R., Kaplan, L. M., Leiter, L. A., Rubino, F., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.014 · Cited by 177
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01817.x · Cited by 173
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
Kaswala, D. H., Lai, M., & Afdhal, N. H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4079-4 · Cited by 172
The F ramingham risk score and heart disease in nonalcoholic fatty liver disease
Treeprasertsuk, S., Leverage, S., Adams, L. A., Lindor, K. D., Sauver, J. L. S., & Angulo, P. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02753.x · Cited by 171
Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome
Sung, K., Wild, S. H., Kwag, H. J., & Byrne, C. D. (2012) · Diabetes Care · doi:10.2337/dc12-0515 · Cited by 170
Tikkanen, M. J., Fayyad, R. S., Færgeman, O., OLSSON, A. G., Wun, C., Laskey, R. E., Kastelein, J. J. P., Holme, I., & Pedersen, T. R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.024 · Cited by 164
Wong, V. W., Wong, G. L., Yeung, J. C., Fung, C. C. Y., Chan, J. K., Chang, Z. H., Kwan, C. T., Lam, H., Limquiaco, J. L., Chim, A. M., et al. (2015) · Hepatology · doi:10.1002/hep.28253 · Cited by 163
Sinn, D. H., Kang, D., Chang, Y., Ryu, S., Gu, S., Kim, H., Seong, D., Cho, S. J., Yi, B.-K., Park, H.-D., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311854 · Cited by 163
Ajmera, V. H., Belt, P. H., Wilson, L., Gill, R. M., Loomba, R. S., Kleiner, D. E., Neuschwander‐Tetri, B. A., & Terrault, N. A. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.026 · Cited by 163
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Chang, Y., Cho, Y. K., Kim, Y., Sung, E., Ahn, J., Jung, H., Yun, K. E., Shin, H., & Ryu, S. (2019) · Hepatology · doi:10.1002/hep.30170 · Cited by 162
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
Tripodi, A., Fracanzani, A. L., Chantarangkul, V., Primignani, M., & Fargion, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.025 · Cited by 161
Pacana, T., Cazanave, S. C., Verdianelli, A., Patel, V. A., Min, H., Mirshahi, F., Quinlivan, E. P., & Sanyal, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136822 · Cited by 157
Käräjämäki, A. J., Pätsi, O.-P., Savolainen, M. J., Kesäniemi, Y. A., Huikuri, H. V., & Ukkola, O. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142937 · Cited by 157
Zhou, Y., Zhou, X., Wu, S., Fan, D., Poucke, S. V., Chen, Y., Fu, S., & Zheng, M. (2018) · Hepatology Communications · doi:10.1002/hep4.1155 · Cited by 156
Puchner, S. B., Lu, M. T., Mayrhofer, T., Liu, T., Pursnani, A. K., Ghoshhajra, B. B., Truong, Q. A., Wiviott, S. D., Fleg, J. L., Hoffmann, U., et al. (2014) · Radiology · doi:10.1148/radiol.14140933 · Cited by 153
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Coulon, S., Francque, S., Colle, I. O., Verrijken, A., Blomme, B., Heindryckx, F., Munter, S. D., Prawitt, J., Caron, S., Staels, B., et al. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.001 · Cited by 148
Kargiotis, K., Athyros, V. G., Giouleme, O., Katsiki, N., Katsiki, E., Anagnostis, P. G., Boutari, C., Doumas, M., Karagiannis, A., & Mikhailidis, D. P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7860 · Cited by 147
Francque, S., Laleman, W., Verbeke, L., Steenkiste, C. V., Casteleyn, C. R., Kwanten, W. J., Dyck, C. V., D'Hondt, M., Ramon, A., Vermeulen, W., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.103 · Cited by 136
Targher, G., Mantovani, A., Pichiri, I., Rigolon, R., Dauriz, M., Zoppini, G., Morani, G., Vassanelli, C., & Bonora, E. (2013) · Clinical Science · doi:10.1042/cs20130036 · Cited by 129
Mantovani, A., Rigamonti, A., Bonapace, S., Bolzan, B., Pernigo, M., Morani, G., Franceschini, L., Bergamini, C., Bertolini, L., Valbusa, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0091 · Cited by 129
Nascimbeni, F., Aron‐Wisnewsky, J., Pais, R., Tordjman, J., Poitou, C., Charlotte, F., Bédossa, P., Poynard, T., Clément, K., Ratziu, V., et al. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2015-000075 · Cited by 123
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 115
Said, A., & Akhter, A. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.0284 · Cited by 111
Nakahara, T., Hyogo, H., Kimura, Y., Ishitobi, T., Arihiro, K., Aikata, H., Takahashi, S., & Chayama, K. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01034.x · Cited by 110
Pisto, P., Santaniemi, M., Bloigu, R., Ukkola, O. H., & Kesäniemi, Y. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004973 · Cited by 105
Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population
Hung, C., Tseng, P., Tu, C., Chen, C.-C., Liao, W., Lee, Y., Chiu, H., Lin, H., Ho, Y., Yang, W., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001820 · Cited by 104
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Valbusa, F., Bertolini, L., Zenari, L., Pichiri, I., Dauriz, M., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.04.003 · Cited by 101
Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
Zeb, I., Li, D., Budoff, M. J., Katz, R., Lloyd‐Jones, D. M., Agatston, A. A., Blumenthal, R. S., Blaha, M. J., Blankstein, R., Carr, J. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.070 · Cited by 101
Lipoprotein subclass metabolism in nonalcoholic steatohepatitis
Männistö, V., Simonen, M., Soininen, P., Tiainen, M., Kangas, A. J., Kamińska, D., Venesmaa, S., Käkelä, P., Kärjä, V. J., Gylling, H., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p054387 · Cited by 100
Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation
Sinner, M. F., Wang, N., Fox, C. S., Fontes, J. D., Rienstra, M., Magnani, J. W., Vasan, R. S., Calderwood, A. H., Pencina, M. J., SULLIVAN, L. M., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.021 · Cited by 99
Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L. R., Donnelly, L. A., Colhoun, H. M., Doney, A. S. F., Dillon, J. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039362 · Cited by 99
Jaruvongvanich, V., Wirunsawanya, K., Sanguankeo, A., & Upala, S. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.09.002 · Cited by 98
Pickhardt, P. J., Hahn, L., del Río, A. M., Park, S. H., Reeder, S. B., & Said, A. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11367 · Cited by 90
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
Petta, S., Valenti, L. V. C., Marchesini, G., Marco, V. D., Licata, A., Cammà, C., Barcellona, M. R., Cabibi, D., Donati, B., Fracanzani, A. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074089 · Cited by 88
Hyogo, H., Ikegami, T., Tokushige, K., Hashimoto, E., Inui, K., Matsuzaki, Y., Tokumo, H., Hino, F., & Tazuma, S. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00849.x · Cited by 88
Athyros, V. G., Γιουλεμέ, Ό., Ganotakis, E. S., Elisaf, M., Τζιόμαλος, Κ., Vassiliadis, T. G., Liberopoulos, E. N., Theocharidou, E., Karagiannis, A. I., & Mikhailidis, D. P. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.25554 · Cited by 85
Corey, K. E., Klebanoff, M. J., Tramontano, A. C., Chung, R. T., & Hur, C. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4044-2 · Cited by 84
The Myth of Statin-Induced Hepatotoxicity
Bader, T. F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.102 · Cited by 83
Keskin, M., Hayıroğlu, M. İ., Uzun, A. O., Güvenç, T. S., Şahin, S., & Kozan, Ö. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.107 · Cited by 83
Mantovani, A. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00005 · Cited by 77
Park, H. E., Kwak, M., Kim, D., Kim, M.-K., Cha, M., & Choi, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1525 · Cited by 76
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease
Sönmez, A., Nikolić, D., Doğru, T., Erçin, C. N., Genç, H., Cesur, M., Tapan, S., Karslıoğlu, Y., Montalto, G., Banach, M., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.03.010 · Cited by 75
Hameed, B., Terrault, N. A., Gill, R. M., Loomba, R. S., Chalasani, N., Hoofnagle, J. H., Natta, M. L. V., & CRN, F. T. N. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14492 · Cited by 74
Self-citationMarkus, M. R. P., Baumeister, S. E., Stritzke, J., Dörr, M., Wallaschofski, H., Völzke, H., & Lieb, W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300556 · Cited by 73
Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders
Lim, S. K., Oh, T. J., & Koh, K. K. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.107 · Cited by 72
Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis
Gill, R. M., Belt, P. H., Wilson, L., Bass, N. M., & Ferrell, L. D. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182254283 · Cited by 69
Shen, H., Shahzad, G., Jawairia, M., Bostick, R. M., & Mustacchia, P. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12944 · Cited by 69
Under-prescription of statins in patients with non-alcoholic fatty liver disease
Ben, M. D., Baratta, F., Polimeni, L., Pastori, D., Loffredo, L., Averna, M. R., Violi, F., & Angelico, F. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.09.011 · Cited by 69
Fracanzani, A. L., Pisano, G., Consonni, D., Tiraboschi, S., Baragetti, A., Bertelli, C., Norata, G. D., Dongiovanni, P., Valenti, L. V. C., Grigore, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162473 · Cited by 63
Bonapace, S., Valbusa, F., Bertolini, L., Pichiri, I., Mantovani, A., Rossi, A., Zenari, L., Barbieri, E., & Targher, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088371 · Cited by 62
Echocardiography and NAFLD (non-alcoholic fatty liver disease)
Trovato, F. M., Martines, G. F., Catalano, D., Musumeci, G., Pirri, C., & Trovato, G. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.180 · Cited by 61
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study
Long, M. T., Yin, X., Larson, M. G., Ellinor, P. T., Lubitz, S. A., McManus, D. D., Magnani, J. W., Stærk, L., Ko, D., Helm, R. H., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005227 · Cited by 58
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
Corey, K. E., Misdraji, J., Gelrud, L. G., Zheng, H., Chung, R. T., & Krauss, R. M. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-100 · Cited by 54
Emre, A., Terzi, S., Çeliker, E., Şahin, S., Yazıcı, S., Erdem, A., Ceylan, U. S., Aşık, M., & YEŞİLÇİMEN, K. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.09.021 · Cited by 52
Non-alcoholic fatty liver disease: a diabetologist’s perspective
Pappachan, J. M., Antonio, F. A., Edavalath, M., & Mukherjee, A. (2013) · Endocrine · doi:10.1007/s12020-013-0087-8 · Cited by 52
Kang, J., Cho, K. I., Kim, S. M., Lee, J. Y., Kim, J. J., Goo, J. J., Kim, K. N., Jhi, J. H., Kim, D. J., Lee, H. G., et al. (2012) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2012.20.3.126 · Cited by 51
Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism
Rouabhia, S., Milić, N., & Abenavoli, L. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.894880 · Cited by 49
Guo, K., Zhang, L., Lu, J., Yu, H., Wu, M., Bao, Y., Chen, H., & Jia, W. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.09.008 · Cited by 44
Kim, J., Lee, W., Park, S. E., Park, C., Lee, W., Oh, K.-W., Park, S., & Rhee, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180118 · Cited by 38
Cardiovascular Effects of the New Weight Loss Agents
Vorsanger, M., Subramanyam, P., WEINTRAUB, H. S., Lamm, S. H., Underberg, J. A., Gianos, E., Goldberg, I. J., & Schwartzbard, A. Z. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.007 · Cited by 33
Oni, E., Kalathiya, R., Aneni, E. C., Martin, S. S., Blaha, M. J., Feldman, T., Agatston, A. S., Blumenthal, R. S., Conceição, R., Carvalho, J. A. M., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.09.044 · Cited by 30
Wu, R., Hou, F., Wang, X., Zhou, Y., Sun, K., Wang, Y., Liu, H., Wu, J., Zhao, R., & Hu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09851-5 · Cited by 30
Ishiba, H., Sumida, Y., Kataoka, S., Kuroda, M., Akabame, S., Tomiyasu, K.-I., Tanaka, M., Arai, M., Taketani, H., Seko, Y., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12665 · Cited by 29
Doğan, S., Çelikbilek, M., Yılmaz, Y. K., Sarıkaya, S., Zararsız, G., Serin, H. İ., Börekçi, E., Akyol, L., Pırtı, İ., & Davarci, S. E. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000286 · Cited by 28
Kim, B. J., Cheong, E. S., Kang, J. G., Kim, B. S., & Kang, J. H. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.01.008 · Cited by 28
Riley, P., Bakir, M. A., O’Donohue, J., & Crook, M. A. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2009.00088.x · Cited by 27
Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
Kumar, M. S., Singh, A., Jaryal, A. K., Ranjan, P., Deepak, K. K., Sharma, S., Ramakrishnan, L., Pandey, R. M., & Vikram, N. K. (2016) · International Journal of Hepatology · doi:10.1155/2016/5160754 · Cited by 23
Ratziu, V., Sanyal, A. J., Francque, S., Sun, W., Wong, V. W., Loomba, R. S., Goodman, Z., Lefebvre, E. A., Aithal, G. P., Harrison, S. A., et al. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)30221-6 · Cited by 18
Yilmaz, Y. N., Yönal, O., Kurt, R., Alahdab, Y. Ö., Ozdogan, O. C., Çelikel, Ç., Ulukaya, E., İmeryüz, N., Kalaycı, C., & Avşar, E. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.12.001 · Cited by 17
Cited by
Targher, G., Byrne, C. D., & Tilg, H. (2020) · Gut · doi:10.1136/gutjnl-2020-320622 · Cited by 827
Harrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32517-6 · Cited by 802
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673
Mantovani, A., Csermely, A., Petracca, G., Beatrice, G., Corey, K. E., Simon, T. G., Byrne, C. D., & Targher, G. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00308-3 · Cited by 674
NAFLD and cardiovascular diseases: a clinical review
Kasper, P., Martin, A., Lang, S., Kütting, F., Goeser, T., Demir, M., & Steffen, H.-M. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01709-7 · Cited by 632
Metadata
- Authors
- Stahl, E. P., Dhindsa, D. S., Lee, S. K., Sandesara, P. B., Chalasani, N. P., & Sperling, L. S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 73
- Issue
- 8
- Pages
- 948-963
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2915480803
- Cited by
- 439
- References
- 172
- FWCI
- 32.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.